Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis

Journal of Thoracic Imaging

Volumn 22, Issue 2, 2007, Pages 120-124

  Shah, Rosita M ^a   Jimenez, Sergio ^b   Wechsler, Richard ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Fibrosis; Ground glass opacity; Interstitial disease; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; MALE; PROGNOSIS; RADIODIAGNOSIS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TIME; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 34249886274     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rti.0000213572.16904.40     Document Type: Article

References (13)

1. Terriff BA, Kwan SY, Chan-Yeung MM, et al. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment a follow-up in 26 patients. Radiology. 1992;184:445-449.
2. Lee JS, Im JG, Ahn JM, et al. Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology. 1992;184:451-454.
3. Remy-Jardin M, Remy J, Wallaert B, et al. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology. 1993;188:499-506.
4. Muller NL, Staples CA, Miller RR, et al. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987;165:731-734.
5. Leung AN, Miller RR, Muller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology. 1993;188:209-214.
6. Wells AU, Rubens MB, duBois RM, et al. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR. 1993;161:1159-1165.
7. Latsi PI, Wells AU. Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opinion Rheumatol. 2003;15:748-755.
8. White B. Interstitial lung diseases in scleroderma. Rheum Dis Clin North Am. 2003;29:371-390.
9. Seely JM, Jones LT, Wallace C, et al. Systemic sclerosis: using high-resolution CT to detect lung disease in children. AJR. 1998;170:691-697.
10. Ooi GC, Mok MY, Tsang KW, et al. Interstitial lung disease in systemic sclerosis. Acta Radiol. 2003;44:258-264.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum. 1980;23:581-590.
12. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1994;149:1583-1590.
13. Kim EA, Johkoh T, Lee KS, et al. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr. 2001;25:757-763.